Dick Menzies receives Distinguished Lecturer Award in Respiratory Sciences
The CIHR-ICRH/CTS lectureship honours Dr. Menzies’s significant contributions in tuberculosis research, both in Canada and internationally
Anti-TB drugs can increase risk of TB re-infection
Treatment leads to changes in gut microbiota, compromising immunity
Four Burning Questions for Madhukar Pai and Dick Menzies on World TB Day
Leading researchers at the McGill International TB Centre and RI-MUHC discuss the conditions that allow TB to flourish and the important role McGill and the RI-MUHC are playing to combat it.
From Patient to Pipette: Unlocking the Insights of Rare Diseases
No diseases are irrelevant, clinician-scientist Donald Vinh explains
Confronting a killer
Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...
Celebrating the life of Dr. Margaret Becklake, a pioneer in clinical epidemiology and health outcomes research
We are all saddened by the passing of Dr. Margaret Becklake on October 17, 2018. Recognized globally for her work in respiratory medicine...
Eva Kaufmann receives award from the German Society for Immunology
Eva Kaufmann, DVM, PhD, a postdoctoral student in the lab of Maziar Divangahi, PhD, at the Research Institute of the McGill University Health...
New means to fight 'un-killable' bacteria in healthcare settings
Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant...
It’s au revoir, not goodbye, to the RI-MUHC summer students
They may be Montreal high school students, international medical residents, or students at any level in between. Their summer research...
Latent TB Treatment: Shorter is Better
Treatment of latent tuberculosis (TB) is set to transform after two studies from the Research Institute of the McGill University Health Centre...